Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Clinical Study of the Safety and Efficacy of YTS109 Cell Injection in Children With Relapsed/Refractory Autoimmune Diseases

NCT07439029 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT07439029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07439029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Clinical Study of the Safety and Efficacy of YTS109 Cell Injection in Children With Relapsed/Refractory Autoimmune Diseases
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
July 31, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis (aav), antiphospholipid syndrome (aps), diffuse systemic sclerosis, idiopathic inflammatory myopathies (iims), sjogren's syndrome (ss), systemic lupus erythematosus (sle)